Ferritin light chain pseudogene 20 (FTLP20)

Ferritin light chain pseudogene 20 (FTLP20) is classified as a pseudogene related to the ferritin light chain (FTL) gene family[5]. Pseudogenes are segments of DNA that resemble functional genes but typically lack the ability to encode functional proteins due to disabling mutations or absence of regulatory elements[5]. The human genome contains multiple ferritin pseudogenes, most of which, including FTLP20, have not been shown to be transcribed or play any direct biological or therapeutic role[5]. While some ferritin family pseudogenes (such as FTH1P3) show transcriptional activity and may have regulatory effects, there is no published evidence that FTLP20 is transcribed, encodes a protein, or participates in cellular processes[5]. FTLP20 does not appear in major gene or drug databases as a therapeutic target or biomarker, and it is not relevant for drug interaction or disease association. Summary of key points: - FTLP20 is a **pseudogene** within the ferritin light chain gene family and **does not encode a functional protein** or act as a therapeutic target[5]. - There is **no evidence for expression, function, or disease relevance** of FTLP20 as of available scientific literature[5]. - FTLP20 should not be considered a valid therapeutic target, biomarker, or candidate for drug modulation. FTLP20 is best regarded as a genomic artifact of ferritin gene family evolution, lacking known biological or clinical significance[5].

Other names

FTLP20FTL-pseudogene 20